{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T17:51:17Z","timestamp":1774115477994,"version":"3.50.1"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/aco.0b013e3282f43c56","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T16:11:29Z","timestamp":1236269489000},"page":"168-177","source":"Crossref","is-referenced-by-count":41,"title":["Role of levosimendan in sepsis and septic shock"],"prefix":"10.1097","volume":"21","author":[{"given":"Bernardo Bollen","family":"Pinto","sequence":"first","affiliation":[]},{"given":"Sebastian","family":"Rehberg","sequence":"additional","affiliation":[]},{"given":"Christian","family":"Ertmer","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Westphal","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/cc4854","article-title":"The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC case mix programme database","volume":"10","author":"Harrison","year":"2006","journal-title":"Crit Care"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/01.CCM.0000261890.41311.E9","article-title":"Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003","volume":"35","author":"Dombrovskiy","year":"2007","journal-title":"Crit Care Med"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/bmj.39346.495880.AE","article-title":"Sepsis: definition, epidemiology, and diagnosis","volume":"335","author":"Lever","year":"2007","journal-title":"Br Med J"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1164\/rccm.2201087","article-title":"Current epidemiology of septic shock: the UB-Rea Network","volume":"168","author":"Annane","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMra043632","article-title":"Management of sepsis","volume":"355","author":"Russell","year":"2006","journal-title":"N Engl J Med"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00134-006-0142-5","article-title":"Septic shock: a heart story since the 1960s","volume":"32","author":"Rabuel","year":"2006","journal-title":"Intensive Care Med"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/01.CCM.0000266683.64081.02","article-title":"Mechanisms of sepsis-induced cardiac dysfunction","volume":"35","author":"Rudiger","year":"2007","journal-title":"Crit Care Med"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.shk.0000129198.53836.15","article-title":"Evaluating myocardial depression in sepsis","volume":"22","author":"Levy","year":"2004","journal-title":"Shock"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00075198-200210000-00003","article-title":"Myocardial dysfunction in the patient with sepsis","volume":"8","author":"Krishnagopalan","year":"2002","journal-title":"Curr Opin Crit Care"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"issue":"suppl","key":"R12-12-20210129","doi-asserted-by":"crossref","first-page":"74G","DOI":"10.1016\/j.amjcard.2005.07.024","article-title":"Randomized clinical trials with levosimendan","volume":"96","author":"Mebazaa","year":"2005","journal-title":"Am J Cardiol"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure (The SURVIVE Randomized Trial)","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"R14-12-20210129","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/eurheartj\/ehi044","article-title":"Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the task force on acute heart failure of the European society of cardiology","volume":"26","author":"Nieminen","year":"2005","journal-title":"Eur Heart J"},{"key":"R15-12-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10741-007-9013-6","article-title":"Algorithm for therapeutic management of acute heart failure syndromes","volume":"12","author":"Chatti","year":"2007","journal-title":"Heart Fail Rev"},{"key":"R16-12-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-007-9014-5","article-title":"Classical inotropes and new cardiac enhancers","volume":"12","author":"Parissis","year":"2007","journal-title":"Heart Fail Rev"},{"key":"R17-12-20210129","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/euhj.2001.3158","article-title":"Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebo-controlled, double-blind study (RUSSLAN)","volume":"23","author":"Moiseyev","year":"2002","journal-title":"Eur Heart J"},{"key":"R18-12-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2003.12.006","article-title":"Stereoselective binding of levosimendan to cardiac troponin C causes Ca2+-sensitization","volume":"486","author":"Sorsaa","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"suppl","key":"R19-12-20210129","doi-asserted-by":"crossref","first-page":"68G","DOI":"10.1016\/j.amjcard.2005.07.023","article-title":"Pharmacology of New Agents for Acute Heart Failure Syndromes","volume":"96","author":"Gheorghiade","year":"2005","journal-title":"Am J Cardiol"},{"key":"R20-12-20210129","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2125.2003.01778.x","article-title":"Population pharmacokinetics of levosimendan in patients with congestive heart failure","volume":"55","author":"Jonsson","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"R21-12-20210129","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2125.2003.02043.x","article-title":"Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan","volume":"57","author":"Antila","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"suppl 2","key":"R22-12-20210129","first-page":"S92","article-title":"Levosimendan reduces mortality when compared with dobutamine in patients receiving beta blockers: The SURVIVE study","volume":"33","author":"Mebazaa","year":"2007","journal-title":"Intensive Care Med"},{"key":"R23-12-20210129","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00101-006-1108-2","article-title":"Role of levosimendan in intensive care treatment of myocardial insufficiency","volume":"56","author":"Rehberg","year":"2007","journal-title":"Anaesthesist"},{"key":"R24-12-20210129","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/0022-2828(95)90009-8","article-title":"Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan","volume":"27","author":"Haikala","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"R25-12-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/B:MCBI.0000049141.37823.19","article-title":"The contractile apparatus as a target for drugs against heart failure: Interaction of levosimendan, a calcium sensitizer, with cardiac troponin c","volume":"266","author":"Sorsa","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"R26-12-20210129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0008-6363(99)00219-9","article-title":"Actin-myosin interaction","volume":"44","author":"Sugiura","year":"1999","journal-title":"Cardiovasc Res"},{"key":"R27-12-20210129","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00005344-199505000-00016","article-title":"Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation","volume":"25","author":"Haikala","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"R28-12-20210129","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00000542-200603000-00024","article-title":"Levosimendan, a New Inotropic and Vasodilator Agent","volume":"104","author":"Toller","year":"2006","journal-title":"Anesthesiology"},{"key":"R29-12-20210129","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1006\/jmcc.1998.0677","article-title":"Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit","volume":"30","author":"Sato","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"R30-12-20210129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005344-200007000-00016","article-title":"Effects of OR-1896, an active metabolite of levosimendan, on contractile force and aequorin light transients in intact rabbit ventricular myocardium","volume":"36","author":"Takahashi","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"R31-12-20210129","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00210-002-0627-x","article-title":"Effects of OR-1896, a metabolite of levosimendan, on force contraction and Ca2+ transients under acidotic condition in aequorin-loaded canine ventricular myocardium","volume":"366","author":"Takahashi","year":"2002","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"R32-12-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2004.11.049","article-title":"Contractile action of levosimendan and epinephrine during acidosis","volume":"507","author":"Toller","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R33-12-20210129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3565(24)36997-6","article-title":"The Novel Calcium Sensitizer Levosimendan Activates the ATP-Sensitive K1 Channel in Rat Ventricular Cells","volume":"283","author":"Yokoshiki","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R34-12-20210129","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0014-2999(01)01350-4","article-title":"Levosimendan is a mitochondrial KATP channel opener","volume":"428","author":"Kopustinskiene","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"R35-12-20210129","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bcp.2004.05.018","article-title":"Potassium-specific effects of levosimendan on heart mitochondria","volume":"68","author":"Kopustinskiene","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"R36-12-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00000539-200001000-00003","article-title":"Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of KATP channels","volume":"90","author":"Kersten","year":"2000","journal-title":"Anesth Analg"},{"key":"R37-12-20210129","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1152\/ajpheart.00421.2003","article-title":"KATP channels and myocardial preconditioning: an update","volume":"285","author":"Gross","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R38-12-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.CP0060010","article-title":"Vasodilating Mechanisms of Levosimendan: Involvement of K+ Channels","volume":"104","author":"Yildiz","year":"2007","journal-title":"J Pharmacol Sci"},{"key":"R39-12-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10557-006-7294-y","article-title":"The role of potassium channels in relaxant effect of levosimendan in rat small mesenteric arteries","volume":"20","author":"Ozdem","year":"2006","journal-title":"Cardiovasc Drugs Ther"},{"key":"R40-12-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1025331617233","article-title":"Functional role of potassium channels in the vasodilating mechanism of levosimendan in porcine isolated coronary artery","volume":"17","author":"Pataricza","year":"2003","journal-title":"Cardiovasc Drugs Ther"},{"key":"R41-12-20210129","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1213\/00000539-200206000-00009","article-title":"An analysis of responses to levosimendan in the pulmonary vascular bed of the cat","volume":"94","author":"De Witt","year":"2002","journal-title":"Anesth Analg"},{"key":"R42-12-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1211\/0022357001773715","article-title":"Comparison of the vasorelaxing effect of cromakalim and the new inodilator, levosimendan, in human isolated portal vein","volume":"52","author":"Pataricza","year":"2000","journal-title":"J Pharm Pharmacol"},{"key":"R43-12-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1742-7843.2004.pto940603.x","article-title":"Levosimendan interacts with potassium channel blockers in human saphenous veins","volume":"94","author":"Hohn","year":"2004","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R44-12-20210129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1025379400395","article-title":"Vasodilating mechanisms of levosimendan","volume":"17","author":"Yokoshiki","year":"2003","journal-title":"Cardiovasc Drugs Ther"},{"key":"R45-12-20210129","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0735-1097(00)00961-X","article-title":"Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure","volume":"36","author":"Nieminen","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R46-12-20210129","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00134-005-2619-z","article-title":"Effects of levosimendan on systemic and regional hemodynamics in septic myocardial dysfunction","volume":"31","author":"Morelli","year":"2005","journal-title":"Intensive Care Med"},{"key":"R47-12-20210129","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1097\/01.CCM.0000230244.17174.4F","article-title":"Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study","volume":"34","author":"Morelli","year":"2006","journal-title":"Crit Care Med"},{"key":"R48-12-20210129","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/01.CCM.0000257238.75346.DB","article-title":"Dear levosimendan, the right ventricular will thank you","volume":"35","author":"Westphal","year":"2007","journal-title":"Crit Care Med"},{"key":"R49-12-20210129","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1097\/01.CCM.0000242157.19347.50","article-title":"Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure","volume":"34","author":"Kerbaul","year":"2006","journal-title":"Crit Care Med"},{"key":"R50-12-20210129","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.CCM.0000257326.96342.57","article-title":"Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction","volume":"35","author":"Missant","year":"2007","journal-title":"Crit Care Med"},{"key":"R51-12-20210129","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1097\/01.CCM.0000275266.33910.8D","article-title":"Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure","volume":"35","author":"Kerbaul","year":"2007","journal-title":"Crit Care Med"},{"key":"R52-12-20210129","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.shk.0000235090.30550.fb","article-title":"Sepsis-induced myocardial dysfunction","volume":"28","author":"Sharma","year":"2007","journal-title":"Shock"},{"key":"R53-12-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00003246-199301000-00010","article-title":"Impaired \u03b2-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial responsiveness to catecholamines","volume":"21","author":"Silverman","year":"1993","journal-title":"Crit Care Med"},{"key":"R54-12-20210129","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1164\/ajrccm.160.4.9808149","article-title":"Sequential changes in autonomic regulation of cardiac myocytes after in vivo endotoxin injection in rat","volume":"160","author":"Abi-Gerges","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R55-12-20210129","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.1073\/pnas.97.17.9753","article-title":"Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock","volume":"97","author":"Macarthur","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"R56-12-20210129","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0008-6363(98)00028-5","article-title":"Myofilament calcium sensitivity is decreased in skinned cardiac fibres of endotoxin-treated rabbits","volume":"38","author":"Tavernier","year":"1998","journal-title":"Cardiovasc Res"},{"key":"R57-12-20210129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1096\/fj.00-0433fje","article-title":"Cardiac contractile impairment associated with increased phosphorylation of troponin I in endotoxemic rats","volume":"15","author":"Tavernier","year":"2001","journal-title":"FASEB J"},{"key":"R58-12-20210129","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1164\/ajrccm.163.2.2002128","article-title":"Phosphorylation-dependent alteration in myofilament Ca2+ sensitivity but normal mitochondrial function in septic heart","volume":"163","author":"Tavernier","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R59-12-20210129","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1097\/00003246-200111000-00022","article-title":"Effects of levosimendan, a novel inotropic calcium sensitizing drug, in experimental septic shock","volume":"29","author":"Oldner","year":"2001","journal-title":"Crit Care Med"},{"key":"R60-12-20210129","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00000542-200509000-00014","article-title":"Cardiac and renal effects of levosimendam, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits","volume":"103","author":"Faivre","year":"2005","journal-title":"Anesthesiology"},{"key":"R61-12-20210129","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00134-006-0519-5","article-title":"Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study","volume":"33","author":"Dubin","year":"2007","journal-title":"Intensive Care Med"},{"key":"R62-12-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/shk.0b013e31804d18f6","article-title":"Cardiovascular effects of levosimendan in the early stages of endotoxemia","volume":"28","author":"Cunha-Goncalves","year":"2007","journal-title":"Shock"},{"key":"R63-12-20210129","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00134-006-0520-z","article-title":"Levosimendan in septic shock: another piece in the puzzle, but many pieces are still lacking","volume":"33","author":"De Backer","year":"2007","journal-title":"Intensive Care Med"},{"key":"R64-12-20210129","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00134-003-1879-8","article-title":"The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts","volume":"29","author":"Behrends","year":"2003","journal-title":"Intensive Care Med"},{"key":"R65-12-20210129","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/01.CCM.0000261889.18102.84","article-title":"Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: Comparison with dobutamine and milrinone","volume":"35","author":"Barraud","year":"2007","journal-title":"Crit Care Med"},{"key":"R66-12-20210129","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1152\/ajprenal.00485.2005","article-title":"Levosimendan protects against experimental endotoxemic acute renal failure","volume":"290","author":"Zager","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"R67-12-20210129","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"R68-12-20210129","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1097\/00003246-199302001-00017","article-title":"Associations between intramucosal acidosis in the gut and organ failure","volume":"21","author":"Fiddian-Green","year":"1993","journal-title":"Crit Care Med"},{"key":"R70-12-20210129","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0140-6736(07)61317-8","article-title":"Catecholamine treatment for shock \u2013 equally good or bad?","volume":"370","author":"Singer","year":"2007","journal-title":"Lancet"},{"key":"R71-12-20210129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1399-6576.2005.00541.x","article-title":"Successful reversal of resistant hypodinamic septic shock with levosimendan","volume":"49","author":"Matejovic","year":"2005","journal-title":"Acta Anaesthesiol Scand"},{"key":"R72-12-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00134-004-2502-3","article-title":"Levosimendan in septic cardiac failure","volume":"31","author":"Noto","year":"2005","journal-title":"Intensive Care Med"},{"key":"R73-12-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/bja\/aem225","article-title":"Levosimendan in septic shock: a case series","volume":"99","author":"Powell","year":"2007","journal-title":"Br J Anaesth"},{"key":"R74-12-20210129","first-page":"9","article-title":"Cost analysis of the treatment of acute decompensated heart failure. Levosimendan versus dobutamine","volume":"85","author":"Oliveira","year":"2005","journal-title":"Arq Bras Cardiol"},{"key":"R75-12-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1388-9842(02)00246-5","article-title":"Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial","volume":"5","author":"Cleland","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"R77-12-20210129","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2004.01.073","article-title":"Effects of Levosimendan on Circulating Proinflammatory Cytokines and Soluble Apoptosis Mediators in Patients With Decompensated Advanced Heart Failure","volume":"93","author":"Parissis","year":"2004","journal-title":"Am J Cardiol"},{"key":"R78-12-20210129","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejheart.2005.02.002","article-title":"The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine","volume":"7","author":"Avgeropoulou","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"R79-12-20210129","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.amjcard.2006.01.068","article-title":"Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure","volume":"98","author":"Adamopoulos","year":"2006","journal-title":"Am J Cardiol"},{"key":"R80-12-20210129","doi-asserted-by":"crossref","first-page":"S441","DOI":"10.1097\/01.CCM.0000278049.48333.78","article-title":"Mitochondrial function in sepsis: acute phase versus multiple organ failure","volume":"35","author":"Singer","year":"2007","journal-title":"Crit Care Med"},{"key":"R81-12-20210129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/cc1824","article-title":"Bench-to-bedside review: Cytopathic hypoxia","volume":"6","author":"Fink","year":"2002","journal-title":"Crit Care"},{"key":"R82-12-20210129","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cardiores.2006.07.011","article-title":"Role of KATP channels in sepsis","volume":"72","author":"Buckley","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R83-12-20210129","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med"},{"key":"R84-12-20210129","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/shk.0b013e318050c836","article-title":"Role of adenosine triphosphate-sensitive potassium channel inhibition in shock states: physiology and clinical implications","volume":"28","author":"Lange","year":"2007","journal-title":"Shock"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0b013e3282f43c56","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T01:29:49Z","timestamp":1738978189000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001503-200804000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0b013e3282f43c56","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}